While SHOX2 and RASSF1A serve as promising cancer biomarkers and exhibit commendable diagnostic capabilities for detecting lung cancer in alveolar lavage fluid, they cannot discern the pathological subtypes. This evidence concerns the gene SHOX2 and lung carcinoma.